Pembroke, Bermuda
Covidien Ltd. (NYSE: COV; BSX: COV) announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per common share. The dividend is payable on November 9, 2007 to shareholders of record on October 9, 2007.
"This declaration, our first dividend as a public company, is an important milestone for the Company and its investors," said President and Chief Executive Officer Richard J. Meelia.
ABOUT COVIDIEN LTD.
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines, including Surgical Devices, Energy-based Devices, Respiratory and Monitoring Solutions, Patient Care and Safety Products, Imaging Solutions, Pharmaceutical Products, Medical Supplies and Retail Products. With 2006 revenue of nearly $10 billion, Covidien has more than 43,000 employees worldwide in 57 countries, and its products are sold in over 130 countries. For additional information, please visit our website, www.covidien.com.
Source: Business Wire (Business Wire India)
